Return‐to‐Sport Assessment After Medial Patellofemoral Ligament Reconstruction Shows Substantial Variability in Objective Criteria Authors: Louis Kang, Gavin H Ward, Mario Hevesi, Kelechi R Okoroha, Daniel B F Saris, Christopher L Camp, Aaron J Krych, Adam J Tagliero Published: 2026 ABSTRACT AbstractPurposeTo evaluate objective return‐to‐sport (RTS) outcomes and limb symmetry index (LSI) data after primary medial patellofemoral ligament reconstruction (MPFLR) in patients with patellar instability.MethodsA systematic search of Scopus, PubMed, CINAHL, and Embase (2000‐2024) identified studies reporting RTS outcomes and LSI‐based performance testing in patients undergoing primary MPFLR. Clinical and observational studies reporting objective metrics such as isokinetic strength and hop testing were included.ResultsSix studies including 243 patients (64% women, mean age 19.4 years) undergoing primary MPFLR were included. Several studies included patients undergoing concomitant bone procedures (41%), such as tibial tubercle osteotomy or trochleoplasty. Objective RTS testing commonly included isokinetic strength (4 studies), hop testing (3 studies), and Y‐Balance testing (2 studies). Follow‐up testing ranged from 6 to 8 months postoperatively. Reported LSI values ranged from 83% to 94% for isokinetic flexion, 70% to 96% for isokinetic extension, 85% to 93% for single hop, and 90% to 97% for triple hop. Time to RTS ranged from 6.1 to 8.1 months across studies, with RTS rates from 85% to 100%. However, only 14% to 40% of patients met all study‐specific RTS criteria when reported. Testing protocols and thresholds varied across studies, contributing to heterogeneity in outcomes.ConclusionsFew studies reporting RTS outcomes after MPFLR incorporate LSI measures as part of RTS assessment, and only a minority define explicit RTS criteria based on objective testing. Among studies that reported LSI, quadriceps strength frequently remained below 90% LSI at the time of RTS. Despite high reported RTS rates, substantial variability exists in RTS assessment after MPFLR.Level of EvidenceLevel IV, systematic review of Level III to IV studies. Patellar instability refers to the subluxation or dislocation of the patella, most common laterally. 1 , 2 Adolescents and active women are at greater risk. 1 , 2 , 3 Key anatomical and demographic risk factors include trochlear dysplasia, patella alta, elevated tibial tubercle‐trochlear groove distance, and younger age at first dislocation, with recurrence risk rising substantially when multiple factors are present (30%‐60% with 2 factors, 70%‐79% with 3). 2 , 3 , 4 , 5 , 6 Nonoperative management—including physical therapy, immobilization, and bracing—is typically first line for first‐time dislocations, whereas surgery is considered for recurrent instability or associated osteochondral injury. 2 , 7 Medial patellofemoral ligament reconstruction (MPFLR) is the preferred surgical approach because of favorable functional outcomes and lower recurrence rates compared with other soft‐tissue stabilizing procedures. 2 , 4 , 8 , 9 Given the high incidence in active individuals, return to sport (RTS) is an important consideration. A systematic review by Platt et al. reported RTS rates of 92% at a mean of 6.7 months after MPFLR, with 71% returning to their preinjury level of competition. 10 Recurrence rates after MPFLR have been reported to range from 0% to 38%. 10 , 11 Fear of reinjury is common, and objective RTS guidelines can help provide reassurance regarding rehabilitation adequacy and lower extremity strength. 10 However, evidence‐based criteria for RTS after MPFLR remain poorly defined. Fisher et al. found limited information on the later stages of rehabilitation, including criteria‐based evaluation, in their systematic review of MPFLR rehabilitation. 12 Similarly, Zaman et al. found that no studies provided specific objective measures for RTS after MPFLR. 13 Notably, both reviews included patients undergoing MPFL repair, limiting their external validity to MPFLR. To address this gap, the purpose of this study was to evaluate objective RTS outcomes and limb symmetry index (LSI) data after primary MPFLR in patients with patellar instability. By aggregating current evidence, this review aims to clarify the use of objective measures for RTS after MPFLR and highlight gaps in reporting. We hypothesized that LSI data would be limited and variable, whereas overall reported RTS rates would remain relatively high. METHODS Search Strategy The authors strictly adhered to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines. 14 After registration with PROSPERO (CRD42025648502), a literature search of Scopus, PubMed, CINAHL, and Embase was performed to identify articles published from 2000 to 2024, with searches executed between September and December 2024. Search terms were structured according to the PICOS framework: •Population (P): patients with patellar instability or patellofemoral instability Population (P): patients with patellar instability or patellofemoral instability •Intervention (I): primary MPFLR Intervention (I): primary MPFLR •Comparison (C): not applicable Comparison (C): not applicable •Outcomes (O): RTS, LSI, hop tests, isokinetic or isometric strength, Y‐Balance testing Outcomes (O): RTS, LSI, hop tests, isokinetic or isometric strength, Y‐Balance testing •Study design (S): clinical studies, cohort studies, and prospective or retrospective observational studies Study design (S): clinical studies, cohort studies, and prospective or retrospective observational studies Within each domain, terms were combined using Boolean operators (AND/OR) to identify relevant studies, as detailed in Supporting Information: Searches were limited to studies published in English and involving human participants. Reference lists of included articles were also screened for additional relevant studies. Eligible articles were filtered through exclusion and inclusion criteria sets. Eligibility Criteria Studies were included if they assessed RTS activity using objective performance measures (e.g., isokinetic or isometric strength testing, hop tests, and Y‐Balance) with reported LSI data; reported patient outcomes, complications, or reoperations; included patients undergoing primary MPFLR, with or without concomitant procedures; were published between 2000 and 2024; and involved human subjects. There were no restrictions on patient age or sex. Studies were excluded if they were not available in full text, not in English, systematic reviews or scoping reviews, conference abstracts, editorials, commentaries, book chapters, other review articles, case reports, or duplicates. Screening, Review, and Risk of Bias Assessment Two authors (L.K., G.H.W.) independently screened the titles and abstracts for relevance. Articles meeting initial criteria were then reviewed in full text by both reviewers to assess eligibility. Discrepancies during investigator screening were reviewed by a sports medicine fellowship‐trained orthopaedic surgeon (A.J.T.). The Risk of Bias in Non‐randomized Studies of Interventions tool was used to assess the risk of bias within the included studies across 7 domains: bias because of confounding, selection of participants, classification of interventions, deviations from intended interventions, missing data, measurement of outcomes, and selection of reported results. Each included study was independently assessed and graded by a member of the orthopaedic sports medicine team. 15 Discrepancies in grading were resolved through discussion and consultation with a sports medicine fellowship‐trained orthopaedic surgeon (A.J.T.). The overall risk of bias for each study is summarized in Figure 1. ROBINS‐I assessment tool presented as a traffic‐light figure plot. (ROBINS‐I, Risk of Bias in Non‐randomized Studies of Interventions.) Data Extraction and Synthesis All eligible study's demographic, clinical outcomes, and LSI data were extracted independently by 2 reviewers (L.K., G.H.W.) and cross‐checked for accuracy. Extracted variables included number of patients, age at surgery, sex, graft type, concomitant procedures, time to RTS, RTS rate, any radiographic measures reported, and follow‐up. Objective performance testing outcomes included isokinetic and isometric strength measures, hop testing, Y‐Balance testing, and patient‐reported outcomes when available. Mean age at the time of surgery was calculated by weighting each study's mean by sample size for descriptive purposes only. Because of substantial heterogeneity in surgical procedures, rehabilitation protocols, RTS testing methods, and follow‐up duration across included studies, no meta‐analysis or inferential statistics were performed. Results were synthesized descriptively, with LSI values, RTS rates, and time to RTS summarized as ranges and study‐level outcomes. The variables collected were intended to characterize patient populations and summarize objective RTS performance after MPFLR. RESULTS Study Selection The literature search yielded 2632 articles. After title and abstract screening, 9 full‐text studies were assessed for eligibility, and 6 studies met all inclusion criteria and were included in this systematic review (Figure 2). 16 , 17 , 18 , 19 , 20 , 21 All studies performed at least 1 objective strength test quantifying LSI for RTS testing. 16 , 17 , 18 , 19 , 20 , 21 PRISMA flow diagram. (MPFL, medial patellofemoral ligament; MPFLR, medial patellofemoral ligament reconstruction; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta‐Analyses.) Study Characteristics and Patient Demographics The included studies encompassed a total of 243 patients (88 men, 155 women) with a mean age of 19.4 years (range of study means, 14.9‐24.0) at the time of surgery (Table 1). Mean follow‐up duration ranged from 6.1 to 47.0 months. The timing of RTS testing ranged from 6 to 8 months across studies. 16 , 17 , 18 , 19 , 20 , 21 TABLE 1Population and Follow‐Up Characteristics of Studies on Return‐to‐Sport Testing With Limb Symmetry Index After MPFLR Author Level of Evidence Retrospective or Prospective Year Comparison Group Present Patients, n Age, yr (Mean ± SD) Sex, Female (%) Autograft MPFLR Allograft MPFLR Concomitant Procedures ∗ Follow‐Up, mo (Mean ± SD or Total Months) Mikashima et al. 18 Level IVRetrospective2006Yes2421.8 ± 4.914 (58%)240None41.0 ± 8.7Krych et al. 19 Level IVRetrospective2016No3917.4 ± 2.816 (41%)327TTO (41%)47.0 ± 16.4Matassi et al. 17 Level IVRetrospective2018No5824.0 ± 3.740 (69%)580None35Saper et al. 21 Level IVRetrospective2019No2814.9 ± 1.020 (71%)1711TTO (36%), DFO (4%), tibial hemiepiphysiodesis (4%), osteochondral fracture fixation (4%), patellar microfracture (4%)7.4 ± 1.6Shams et al. 20 Level IIIProspective2019Yes1616.1 ± 2.710 (62%)———12.7 ± 6.2Hysing‐Dahl et al. 16 Level IVProspective2023No7822.3 ± 6.955 (71%)780TTO or trochleoplasty (81%)6.1 ± 0.8—, not reported by the study; DFO, distal femoral osteotomy; mo, month; MPFLR, medial patellofemoral ligament reconstruction; TTO, tibial tubercle osteotomy; yr, year. *Did not report soft‐tissue concomitant procedures (i.e., lateral release and chondroplasty). Population and Follow‐Up Characteristics of Studies on Return‐to‐Sport Testing With Limb Symmetry Index After MPFLR —, not reported by the study; DFO, distal femoral osteotomy; mo, month; MPFLR, medial patellofemoral ligament reconstruction; TTO, tibial tubercle osteotomy; yr, year. Did not report soft‐tissue concomitant procedures (i.e., lateral release and chondroplasty). Ninety‐three (41%) patients out of a reported 227 underwent concomitant bone procedures (tibial tubercle osteotomy, distal femoral osteotomy, guided growth, osteochondral fixation, patellar fracture fixation, and trochleoplasty). Five studies disclosed graft type used for the MPFLR in 227 patients where 209 (92%) were autograft and 18 (8%) were allograft. 16 , 17 , 18 , 19 , 20 All studies conducted outside the United States used only autograft. 16 , 17 , 18 Functional Outcomes and LSI Testing Reported performance testing measures and patient‐reported outcomes are summarized in Table 2. The most commonly reported objective performance measures included isokinetic strength testing (4 studies), 16 , 18 , 19 , 20 hop testing (3 studies), 16 , 20 , 21 and Y‐Balance testing (2 studies). 16 , 21 Across studies, substantial variability existed in testing protocols and outcome definitions, including differences in isokinetic testing speeds, time to RTS testing, and RTS clearance thresholds. 16 , 17 , 18 , 19 , 20 , 21 Among studies reporting isokinetic strength, Hysing‐Dahl et al. assessed strength at slow speeds (60°/s), Shams et al. used faster speeds (300°/s), Krych et al. reported LSI values at both slow (30°/s) and fast (180°/s) speeds, and Mikashima et al. did not disclose their testing speeds. Across these studies, reported knee flexion LSI values ranged from 83% to 94%, whereas knee extension LSI values ranged from 70% to 96% at the reported postoperative testing timepoints. 16 , 18 , 19 , 20 Hop testing showed single‐hop LSI values ranging from 85% to 94% and triple‐hop LSI values ranging from 90% to 97%. 16 , 20 , 21 Y‐Balance testing was reported inconsistently, with Saper et al. presenting values solely as side‐to‐side differences, whereas Hysing‐Dahl et al. reported both side‐to‐side differences and percentage LSI values. 16 , 21 TABLE 2LSI and Functional Outcomes After Primary MPFL Reconstruction Author n Isokinetic Flexion LSI, % Isokinetic Extension LSI, % Single‐Hop LSI, % Triple‐Hop LSI, % Y‐Balance LSI, % Patient‐Reported Outcomes Postoperative Kujala Score Mikashima et al. 18 2483.9%† 95.8%† ———Kujala score95.2 ± 12.9Krych et al. 19 3983.2% slow, 91.3% fast78.6% slow, 86.7% fast——— Kujala score Tegner score 91.1 ± 6.3Matassi et al. 17 , ∗ 58—— ∗ ∗ ∗ Kujala score Short form 36 92.7 ± 4.9Saper et al. 21 2895.1%‡ 85.3%‡ 89.7%92.3%63% achieved <4‐cm difference between extremities——Shams et al. 20 1690.7% fast88.6% fast93.7%97.2%— IKDC TSK Marx scale Kujala score 95.6 ± 5.3Hysing‐Dahl et al. 16 7893.5% slow70.4% slow84.7%89.5%96.1%—— Note: Isokinetic testing velocities defined as slow: 30°/s to 60°/s and fast: 180°/s to 300°/s. —, outcome not reported by the study; IKDC, International Knee Documentation Committee; LSI, limb symmetry index; MPFL, medial patellofemoral ligament; TSK, Tampa Scale for Kinesiophobia.∗Balance and hop testing protocols differed from other studies.†Isokinetic strength testing parameters not specified.‡Strength measured isometrically at 90° knee flexion, not isokinetically. LSI and Functional Outcomes After Primary MPFL Reconstruction Kujala score Tegner score Kujala score Short form 36 IKDC TSK Marx scale Kujala score Note: Isokinetic testing velocities defined as slow: 30°/s to 60°/s and fast: 180°/s to 300°/s. —, outcome not reported by the study; IKDC, International Knee Documentation Committee; LSI, limb symmetry index; MPFL, medial patellofemoral ligament; TSK, Tampa Scale for Kinesiophobia. Balance and hop testing protocols differed from other studies. Isokinetic strength testing parameters not specified. Strength measured isometrically at 90° knee flexion, not isokinetically. The most frequently used patient‐reported outcome was the Kujala score (4 studies), 19 ‐ 19 , 21 with postoperative scores ranging from 91.1 to 95.6 at final follow‐up. Additional patient‐reported outcome measures included the International Knee Documentation Committee (1 study), 20 Tegner activity scale (1 study), 19 Tampa Scale for Kinesiophobia (1 study), 20 and Marx activity scale (1 study; 20 Table 2). RTS Outcomes, Clearance Criteria, and Timing RTS outcomes and timing are summarized in Table 3. Objective RTS testing was performed at 6 months for 3 studies and between 7 and 8 months for 1 study. 16 , 18 , 19 , 21 Reported overall RTS rates ranged from 85% to 100%, whereas the proportion of patients returning to their preoperative level of sport ranged from 53% to 77% among studies reporting this outcome. 19 ‐ 19 Time to RTS varied depending on surgical factors and concomitant procedures. In the study by Saper et al., patients undergoing concurrent tibial tubercle osteotomy underwent RTS testing slightly later than those undergoing isolated MPFLR (mean 7.9 vs 7.2 months). The longest reported mean time to RTS was 8.1 months, as reported by Krych et al. TABLE 3RTS Outcomes, Time to Return, and Postoperative Complications After Primary MPFL Reconstruction Author n RTS Rate, % RTS at Preop Level, % Time to RTS Complications Recurrent Instability/Reoperation Mikashima et al. 18 24100%76.5%Mean 6.1 ± 0.85 mo2 patients (8%) sustained patellar fractures postoperativelyApprehension test was positive in 1 patient (4%) at follow‐upKrych et al. 19 3985%—Mean 8.1 ± 3.9 mo—5 patients (13%) underwent reoperation: 4 tibial tubercle screw removal and 1 revision MPFL reconstructionMatassi et al. 17 , * 5893%53%—No cases of recurrent dislocation3 patients (5%) experienced additional episodes of subluxationSaper et al. 21 28—— With concomitant TTO, mean 7.9 mo Without concomitant TTO, mean 7.2 mo ——Shams et al. 20 16—————Hysing‐Dahl et al. 16 78——Mean 6.1 ± 0.8 mo—— —, outcome not reported by the study; mo, month; MPFL, medial patellofemoral ligament; Preop, preoperative; RTS, return to sport; TTO, tibial tubercle osteotomy. *Balance and hop testing protocols differed from other studies. RTS Outcomes, Time to Return, and Postoperative Complications After Primary MPFL Reconstruction With concomitant TTO, mean 7.9 mo Without concomitant TTO, mean 7.2 mo —, outcome not reported by the study; mo, month; MPFL, medial patellofemoral ligament; Preop, preoperative; RTS, return to sport; TTO, tibial tubercle osteotomy. Balance and hop testing protocols differed from other studies. Only 3 studies reported explicit RTS clearance criteria incorporating LSI thresholds (Table 4). 16 , 19 , 21 Krych et al. used an LSI threshold of ≥85% for isokinetic quadriceps and hamstring strength to help inform RTS clearance. 19 Hysing‐Dahl et al. applied more stringent criteria, including a ≥95% composite Y‐Balance score, ≤4 cm asymmetry in anterior reach, ≥85% LSI for all single‐hop tests, and ≥90% LSI for isokinetic quadriceps strength. In that study, only 14% met all study‐specific RTS criteria at the time of testing. 16 Saper et al. reported individual RTS thresholds for specific tests, including LSI ≥ 90% across all 4 hop tests and recovery of muscle strength defined as isometric LSI ≥ 90%, but did not specify a composite pass requirement. In their cohort, 32% of patients passed all 4 hop tests. 21 Matassi et al. reported that 40% of patients obtained a “high score” across all functional RTS tests—however, their testing protocols differed from other studies, limiting direct comparison. 17 Overall, despite high reported RTS rates, a relatively small proportion of patients met multiple objective RTS clearance thresholds, showing the variability in RTS definitions, testing protocols, and clearance practices. TABLE 4Objective RTS Testing Frameworks and Clearance Criteria After MPFL Reconstruction Author Objective RTS Testing Results RTS Clearance Criteria/Thresholds Mikashima et al. 18 ——Krych et al. 19 —Isokinetic strength testing ≥85% LSI (did not report % who passed these criteria)Matassi et al. 17 , * 40% obtained a high score in all functional tests 53% obtained a high score in 3/4 parameters evaluated Each test was graded as “very weak,” “weak,” “normal,” “good,” and “very good”Saper et al. 21 32% of patients passed all hop tests 63% achieved Y‐Balance anterior reach within 4‐cm difference of contralateral 44% achieved isometric torque >90% LSI at knee extension 70% achieved isometric torque >90% LSI at knee flexion LSI ≥ 90% on all 4 hop tests LSI ≥ 85%‐90% for quadriceps strength Y‐Balance anterior reach <4 cm asymmetry Shams et al. 20 No differences in isokinetic strength compared with healthy controls Significantly worse scores for hop testing compared with healthy controls —Hysing‐Dahl et al. 16 14% of patients passed all RTS clearance criteria 64% passed Y‐Balance criteria 19% passed isokinetic strength criteria 52% passed all 4 hop test criteria LSI ≥ 95% composite score for Y‐Balance, Y‐Balance anterior reach ≤4 cm asymmetry LSI ≥ 85% for all single hop and LSI ≥ 90% in quadriceps strength —, not reported by the study; LSI, limb symmetry index; MPFL, medial patellofemoral ligament; RTS, return to sport. *Balance and hop testing protocols differed from other studies. Objective RTS Testing Frameworks and Clearance Criteria After MPFL Reconstruction 40% obtained a high score in all functional tests 53% obtained a high score in 3/4 parameters evaluated 32% of patients passed all hop tests 63% achieved Y‐Balance anterior reach within 4‐cm difference of contralateral 44% achieved isometric torque >90% LSI at knee extension 70% achieved isometric torque >90% LSI at knee flexion LSI ≥ 90% on all 4 hop tests LSI ≥ 85%‐90% for quadriceps strength Y‐Balance anterior reach <4 cm asymmetry No differences in isokinetic strength compared with healthy controls Significantly worse scores for hop testing compared with healthy controls 14% of patients passed all RTS clearance criteria 64% passed Y‐Balance criteria 19% passed isokinetic strength criteria 52% passed all 4 hop test criteria LSI ≥ 95% composite score for Y‐Balance, Y‐Balance anterior reach ≤4 cm asymmetry LSI ≥ 85% for all single hop and LSI ≥ 90% in quadriceps strength —, not reported by the study; LSI, limb symmetry index; MPFL, medial patellofemoral ligament; RTS, return to sport. Balance and hop testing protocols differed from other studies. Complications and Recurrent Instability Three studies reported recurrence or revision outcomes specific to the MPFLR cohort, with mean postoperative follow‐up durations of up to 47 months (Table 3). Across the studies reporting these outcomes, 10 out of 117 patients (9%) experienced recurrent patellar instability or underwent subsequent revision surgery after primary MPFLR. 19 ‐ 19 Reported complications included patellar fracture, persistent apprehension, symptomatic subluxation, and hardware removal. 19 ‐ 19 DISCUSSION Across the included studies, reported RTS rates after MPFLR were high (85%‐100%), despite few studies explicitly incorporating LSI thresholds as part of RTS clearance criteria. Commonly used performance measures—including isokinetic strength testing and hop tests—showed generally favorable postoperative LSI values by approximately 6 to 7 months; however, isokinetic quadriceps strength frequently remained below 90% LSI. Substantial variability existed in testing protocols and reporting of objective RTS assessments. A small number of studies were included, none of which performed sex‐based outcome analyses or reported patient‐acceptable outcome thresholds such as minimal clinically important difference, patient acceptable symptom state, or substantial clinical benefit. All studies reported patient‐reported outcomes as group‐level averages, preventing more detailed assessment of individual‐level recovery or threshold achievement. Collectively, these findings highlight a disconnect between reported RTS rates and objective functional recovery after MPFLR and emphasize the need for additional studies reporting objective performance data to support the development of evidence‐based RTS criteria. Objective RTS rehabilitation protocols incorporating standardized performance criteria are well established after anterior cruciate ligament reconstruction (ACLR) and provide a useful contextual framework for MPFLR. 22 , 23 , 24 , 25 , 26 Prior ACLR literature has shown higher reinjury rates and lower RTS rates when athletes RTS without completion of structured RTS testing or with quadriceps LSI < 90%. 22 , 24 , 25 Accordingly, recent recommendations have emphasized the use of multiple functional tests in combination with quadriceps and hamstring strength symmetry ≥90% as RTS criteria after ACLR. 26 In contrast, objective RTS criteria after MPFLR remain poorly defined. Systematic reviews by Koshino et al. and Zaman et al. identified quadriceps strengthening as a common rehabilitation focus but noted a lack of objective criteria. 13 , 27 Similarly, Fisher et al. conducted a review of relevant patient‐reported outcome measures and concluded that current measures such as Kujala, Lysholm, Fulkerson, and Tegner lack sufficient specificity to determine readiness for RTS after MPFL stabilization surgery. 12 Notably, Zaman et al. and Fisher et al. included patients undergoing MPFL repair in addition to MPFLR. 12 , 13 Ménétrey et al. proposed RTS criteria for patellar stabilization surgery, modeled on the ACLR literature, including (1) no pain, (2) no effusion, (3) no patellofemoral instability, (4) full range of motion, (5) LSI strength of 85% to 90%, and (6) excellent dynamic stability, providing a potential benchmark for objective evaluation. 28 In the present review, reported LSI values after MPFLR show wide variability across strength and functional performance measures at the time of RTS testing. Isokinetic quadriceps and hamstring strength LSI values ranged from approximately 70% to 96% and 83% to 94%, respectively, whereas functional hop testing showed LSI values ranging from 85% to 94% for single hop and 90% to 97% for triple hop. Although these values overlap with thresholds commonly cited in ACLR rehabilitation, only 3 studies explicitly incorporated LSI‐based criteria for RTS clearance, and only a minority of patients met all defined criteria at the time of testing. 16 , 21 , 25 Matassi et al. used an alternative battery of functional tests, such as 1‐ and 2‐leg stability on a balance board and 1‐ and 2‐leg counter movement jumps wearing a weighted belt, and was therefore excluded from LSI data synthesis. 17 Additional studies with standardized objective testing are needed to inform evidence‐based RTS criteria tailored to patellar instability cohorts. Several studies have examined RTS rates after MPFL surgery. In a systematic review of isolated MPFLR patients, Schneider et al. reported that 84% returned to sport at preinjury levels. 21 Similarly, Platt et al. found a >90% RTS rate at a mean of 6.7 months, although 30% of patients did not return to their previous level of play. 10 Consistent with these findings, studies included in the present review reported mean time to RTS ranging from 6 to 8 months, with overall RTS rates of 85% to 100%. However, interpretation of time to RTS should consider that 41% of patients in the included studies underwent concomitant bone procedures, which may have necessitated modified rehabilitation protocols, possibly affecting weight‐bearing and range‐of‐motion progression and potentially prolonging RTS timelines. Despite this heterogeneity, the observed RTS timelines align closely with those reported in prior systematic reviews. The level of sport returned to was inconsistently reported by the studies in this review, limiting conclusions regarding successful return to preinjury competition. Further studies reporting both level of return and longevity of sports participation after MPFLR are needed to better contextualize RTS outcomes. Reported recurrence rates after MPFLR in the present review were low, although slightly higher than rates reported in larger systematic reviews of isolated MPFLR. Koshino et al. conducted a systematic review of MPFLR with and without tibial tubercle osteotomy among 3493 knees and found an overall recurrent instability rate of 3.7%. 27 Two other systematic reviews by Schneider et al. and Platt et al. documented recurrent instability rates of 1.9% and 1.2%, respectively, after MPFLR. 10 , 29 These 2 studies also had high RTS rates of 84% and 93%, respectively. The discrepancy with the present study's recurrence rate of 9% may reflect cohort and procedural differences, including a relatively high proportion of patients (41%) undergoing concomitant bony procedures, small sample sizes, and variability in rehabilitation protocols. Additionally, not all included studies clearly distinguished isolated MPFLR from combined procedures, which may have contributed to higher observed recurrence. Overall, available evidence supports MPFLR as an effective treatment for patellar instability with generally low short‐term recurrence rates, though recurrence risk may be higher in those undergoing combined procedures. Interest in MPFLR outcomes continues to grow, as evidenced by the recency of research in the present. Six of the 7 studies in the present review were published within the past decade. Limitations The present study is not without limitations. There was considerable heterogeneity in concomitant procedures performed with MPFLR and in rehabilitation protocols, which likely influenced functional outcomes. Although this reflects real‐world variability in the patellofemoral instability population, it precluded quantitative pooling of data and necessitated descriptive synthesis. The present study's findings are also limited by the level of evidence of included studies, which were primarily Level IV studies. Additionally, 92% of patients received autograft MPFLR, which may affect knee flexion and hop performance outcomes and limit generalizability to settings where allograft is more commonly used. CONCLUSIONS Few studies reporting RTS outcomes after MPFLR incorporate LSI measures as part of RTS assessment, and only a minority defined explicit RTS criteria based on objective testing. Among studies that reported LSI, quadriceps strength frequently remained below 90% LSI at the time of RTS. Despite high reported RTS rates, substantial variability exists in RTS assessment after MPFLR. SUPPORTING INFORMATION Additional supporting information can be found online in the Supporting Information section. DISCLOSURES The authors (M.H., K.R.O., D.B.F.S., C.L.C., A.J.K., A.J.T.) declare the following financial interests/personal relationships which may be considered as potential competing interests: M.H. reports relationships with DJO‐Enovis, Moximed, Stryker, and Vericel that include paid consulting; Elsevier that includes publishing royalties and financial or material support; and Journal of Cartilage and Joint Preservation that includes editorial or governing board. K.R.O. reports a relationship with Smith & Nephew that includes other professional activities and Video Journal of Sports Medicine that includes editorial or governing board. D.B.F.S. reports relationships with Smith+Nephew, Relive Biotechnologies, and ON Foundation that include other professional activities and AAOS devices and biotech comm that includes board membership. C.L.C. reports relationships with Arthrex, Zimmer Biomet Holdings, and Gemini Mountain Medical that include consulting or advisory; Springer Healthcare that includes equity or stocks; and Major League Baseball that includes funding grants. A.J.K. reports relationships with American Journal of Sports Medicine and Springer that include editorial or governing board; Arthrex that includes IP royalties and paid consulting; and Arthroscopy Association of North America and International Cartilage Repair Society that include board or committee membership. A.J.T. reports a relationship with American Orthopaedic Society for Sports Medicine that includes board or committee membership. The other authors (L.K., G.H.W.) declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Supporting information Supplementary Material REFERENCES Associated Data Supplementary Materials Supplementary Material